Is angiotensin-converting-enzyme inhibition renoprotective in young patients with IgA nephropathy?

Affiliations

Comment

Philip K T Li. Nat Clin Pract Nephrol. 2007 Nov.

. 2007 Nov;3(11):594-5.

doi: 10.1038/ncpneph0611. Epub 2007 Sep 11.

¹ Prince of Wales Hospital, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong. philipli@cuhk.edu.hk

No abstract available

Comment on

IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T. Coppo R, et al. J Am Soc Nephrol. 2007 Jun;18(6):1880-8. doi: 10.1681/ASN.2006040347. Epub 2007 May 18. J Am Soc Nephrol. 2007. PMID: 17513327 Clinical Trial.